Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melanie Föcking

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Biochemical and Biophysical Research Communications|October 11, 2005
Caffeine-mediated enhancement of glucocorticoid receptor activity in human osteoblastic cellsMelanie Föcking, Diane Schmiegelt, Thorsten Trapp
Brain, Behavior, & Immunity - Health|July 11, 2024
Complement C4, C4A and C4a - What they do and how they differMeike Heurich, Melanie Föcking, David Cotter
Acta Neurobiologiae Experimentalis|February 3, 2007
Proteomics of experimental stroke in miceMelanie Föcking, Michael Besselmann, Thorsten Trapp
Biochemical and Biophysical Research Communications|May 3, 2003
Chronic glucocorticoid receptor activation impairs CREB transcriptional activity in clonal neuronsMelanie Föcking, Irmgard Hölker, Thorsten Trapp
Schizophrenia Research|March 3, 2015
Proteomic pathway analysis of the hippocampus in schizophrenia and bipolar affective disorder implicates 14-3-3 signaling, aryl hydrocarbon receptor signaling, and glucose metabolism: potential roles in GABAergic interneuron pathologyKlaus Oliver Schubert, Melanie Föcking, David R Cotter
Proteomics|November 27, 2015
Proteome and pathway effects of chronic haloperidol treatment in mouse hippocampusKlaus Oliver Schubert, Melanie Föcking, Kieran Wynne, et al.
Early Intervention in Psychiatry|August 2, 2019
Role of inflammation in the pathogenesis of schizophrenia: A review of the evidence, proposed mechanisms and implications for treatmentDavid Mongan, Matthew Ramesar, Melanie Föcking, et al.
Proteomics. Clinical Applications|December 6, 2016
Human brain proteome in health and diseaseRenã A S Robinson, Melanie Föcking, Daniel Martins-de-Souza
Molecular Psychiatry|July 6, 2021
Dysregulation of complement and coagulation pathways: emerging mechanisms in the development of psychosisMeike Heurich, Melanie Föcking, David Mongan, et al.
Early Intervention in Psychiatry|March 2, 2021
Omega-3 fatty acid in ultra-high-risk psychosis: A systematic review based on functional outcomeSubash Raj Susai, Sophie Sabherwal, David Mongan, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Biochemical and Biophysical Research Communications|October 11, 2005
Caffeine-mediated enhancement of glucocorticoid receptor activity in human osteoblastic cellsMelanie Föcking, Diane Schmiegelt, Thorsten Trapp
Brain, Behavior, & Immunity - Health|July 11, 2024
Complement C4, C4A and C4a - What they do and how they differMeike Heurich, Melanie Föcking, David Cotter
Acta Neurobiologiae Experimentalis|February 3, 2007
Proteomics of experimental stroke in miceMelanie Föcking, Michael Besselmann, Thorsten Trapp
Biochemical and Biophysical Research Communications|May 3, 2003
Chronic glucocorticoid receptor activation impairs CREB transcriptional activity in clonal neuronsMelanie Föcking, Irmgard Hölker, Thorsten Trapp
Schizophrenia Research|March 3, 2015
Proteomic pathway analysis of the hippocampus in schizophrenia and bipolar affective disorder implicates 14-3-3 signaling, aryl hydrocarbon receptor signaling, and glucose metabolism: potential roles in GABAergic interneuron pathologyKlaus Oliver Schubert, Melanie Föcking, David R Cotter
Proteomics|November 27, 2015
Proteome and pathway effects of chronic haloperidol treatment in mouse hippocampusKlaus Oliver Schubert, Melanie Föcking, Kieran Wynne, et al.
Early Intervention in Psychiatry|August 2, 2019
Role of inflammation in the pathogenesis of schizophrenia: A review of the evidence, proposed mechanisms and implications for treatmentDavid Mongan, Matthew Ramesar, Melanie Föcking, et al.
Proteomics. Clinical Applications|December 6, 2016
Human brain proteome in health and diseaseRenã A S Robinson, Melanie Föcking, Daniel Martins-de-Souza
Molecular Psychiatry|July 6, 2021
Dysregulation of complement and coagulation pathways: emerging mechanisms in the development of psychosisMeike Heurich, Melanie Föcking, David Mongan, et al.
Early Intervention in Psychiatry|March 2, 2021
Omega-3 fatty acid in ultra-high-risk psychosis: A systematic review based on functional outcomeSubash Raj Susai, Sophie Sabherwal, David Mongan, et al.
Pageof 5